CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round ...
SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced that it has signed an ...
WELLESLEY HILLS, Mass., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (CLYM), a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results